Literature DB >> 10192708

Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections.

R A Smego1, J Frean, H J Koornhof.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10192708     DOI： 10.1007/s100960050219

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  40 in total

1.  The Yersinia pestis Rcs phosphorelay inhibits biofilm formation by repressing transcription of the diguanylate cyclase gene hmsT.

Authors:  Yi-Cheng Sun; Xiao-Peng Guo; B Joseph Hinnebusch; Creg Darby
Journal:  J Bacteriol       Date:  2012-02-10       Impact factor: 3.490

Review 2.  Yersinia Type III Secretion System Master Regulator LcrF.

Authors:  Leah Schwiesow; Hanh Lam; Petra Dersch; Victoria Auerbuch
Journal:  J Bacteriol       Date:  2015-12-07       Impact factor: 3.490

3.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

4.  X-ray crystal structures of the pheromone-binding domains of two quorum-hindered transcription factors, YenR of Yersinia enterocolitica and CepR2 of Burkholderia cenocepacia.

Authors:  Youngchang Kim; Gekleng Chhor; Ching-Sung Tsai; Gabriel Fox; Chia-Sui Chen; Nathan J Winans; Robert Jedrzejczak; Andrzej Joachimiak; Stephen C Winans
Journal:  Proteins       Date:  2017-07-24

5.  The descriptive epidemiology of yersiniosis: a multistate study, 2005-2011.

Authors:  Apurba Chakraborty; Kenneth Komatsu; Matthew Roberts; Jim Collins; Jennifer Beggs; George Turabelidze; Tom Safranek; Jean-Marie Maillard; Linda J Bell; David Young; Nicola Marsden-Haug; Rachel F Klos; Mark S Dworkin
Journal:  Public Health Rep       Date:  2015 May-Jun       Impact factor: 2.792

6.  Yersinia Yop-specific IgA antibodies in Hungarian blood donors.

Authors:  A Sonnevend; E Czirók; T Pál
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

7.  Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Authors:  Rémi Porte; Laurye Van Maele; Natalia Muñoz-Wolf; Benoit Foligné; Laure Dumoutier; Julien Tabareau; Delphine Cayet; Pierre Gosset; Nicolas Jonckheere; Isabelle Van Seuningen; José A Chabalgoity; Michel Simonet; Mohamed Lamkanfi; Jean-Christophe Renauld; Jean-Claude Sirard; Christophe Carnoy
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

8.  Yersinia pseudotuberculosis Blocks Neutrophil Degranulation.

Authors:  Nayyer Taheri; Anna Fahlgren; Maria Fällman
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

9.  Characterization of rabbit antibodies for immunochemical detection of Yersinia enterocolitica.

Authors:  I Hochel; J Skvor
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.099

10.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.